GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Linical Co Ltd (TSE:2183) » Definitions » EV-to-EBIT

Linical Co (TSE:2183) EV-to-EBIT : 3.36 (As of May. 29, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Linical Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Linical Co's Enterprise Value is 円2,276 Mil. Linical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was 円678 Mil. Therefore, Linical Co's EV-to-EBIT for today is 3.36.

The historical rank and industry rank for Linical Co's EV-to-EBIT or its related term are showing as below:

TSE:2183' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.18   Med: 17.03   Max: 244406.63
Current: 3.36

During the past 13 years, the highest EV-to-EBIT of Linical Co was 244406.63. The lowest was 3.18. And the median was 17.03.

TSE:2183's EV-to-EBIT is ranked better than
55.56% of 477 companies
in the Biotechnology industry
Industry Median: 8.26 vs TSE:2183: 3.36

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Linical Co's Enterprise Value for the quarter that ended in Sep. 2024 was 円4,151 Mil. Linical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was 円678 Mil. Linical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 16.33%.


Linical Co EV-to-EBIT Historical Data

The historical data trend for Linical Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Linical Co EV-to-EBIT Chart

Linical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.73 46.40 17.91 8.80 6.42

Linical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.84 10.27 7.01 6.42 14.10

Competitive Comparison of Linical Co's EV-to-EBIT

For the Biotechnology subindustry, Linical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Linical Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Linical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Linical Co's EV-to-EBIT falls into.


;
;

Linical Co EV-to-EBIT Calculation

Linical Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2276.292/677.866
=3.36

Linical Co's current Enterprise Value is 円2,276 Mil.
Linical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円678 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Linical Co  (TSE:2183) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Linical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) =EBIT / Enterprise Value (Q: Sep. 2024 )
=677.866/4150.798
=16.33 %

Linical Co's Enterprise Value for the quarter that ended in Sep. 2024 was 円4,151 Mil.
Linical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円678 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Linical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Linical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Linical Co Business Description

Traded in Other Exchanges
N/A
Address
1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.

Linical Co Headlines

No Headlines